Fundraising Fox

Ophthotech

New York, US · Delaware corporation · 4 known investors

Biotech

Founders & leadership

DG
David GuyerFounder
GS
Glenn SblendorioExecutive
MA
Mike Atiehin
DR
David RedlickNamed on SEC filing
KW
Keith WestbyNamed on SEC filing
DC
David CarrollNamed on SEC filing
TD
Thomas DyrbergNamed on SEC filing
AB
Axel BolteNamed on SEC filing
JP
Jane Pritchett HendersonNamed on SEC filing

Board

MRMichael Ross
Michael RossinBoard directorSenior Partner at SV Health Investors

Investors · 4

Sofinnova VenturesMenlo Park · $100K – $15M
SV Health InvestorsBoston · $1M – $20M
ClarusreportedCambridge
SV Life SciencesreportedBoston

Reported raises · per SEC filings

Form D private placements

$11.4M disclosed across 1 round · 2018

▶$11.4MraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David RedlickDirector
  • Michael RossDirector
  • Keith WestbyExecutive Officer
  • David CarrollExecutive Officer
  • Thomas DyrbergDirector
  • Glenn SblendorioExecutive Officer, Director
  • Axel BolteDirector
  • Jane Pritchett HendersonDirector
  • David GuyerExecutive Officer, Director
Offering amount
$11.7M
Amount sold
$11.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Vedantu8 shared keywordsVedantu is an online learning platform that provides free chapter-wise NCERT solutions and study materials for Class 12 CBSE students across Science, Commerce, and Arts subjects. It also offers resources for competitive exam preparation such as JEE and NEET, aligned with the latest CBSE syllabus.

Companies competing with Ophthotech for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ophthotech raises $175m - Global Venturingglobalventuring.com · Jun 2013Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista™ Anti-PDGF Combination Therapy in Wet AMD | Fierce Biotechfiercebiotech.com · May 2013Ophthotech Corporation Raises $30 Million in Series B Financing - BioSpacebiospace.com · Dec 2009Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration - BioSpacebiospace.com · Aug 2007PRESS RELEASE: Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration | Fierce Biotechfiercebiotech.com · Aug 2007Samir Patel co-founded Ophthotech raises $30 Millionsiliconindia.com

Frequently asked questions

Who founded Ophthotech?
Ophthotech was founded by David Guyer.
Who are Ophthotech's investors?
Ophthotech's investors include Sofinnova Ventures, SV Health Investors, Clarus, SV Life Sciences.
How much funding has Ophthotech raised?
Ophthotech has disclosed $11.4M raised across 1 round.
Where is Ophthotech headquartered?
Ophthotech is headquartered in New York, US.